Regards, William
Labels
Aicardi-Goutières Syndrome
(2)
Allergen-Specific IgE-RAST-CAP
(6)
Allergy-Hypersensitivity
(18)
Anaphylaxis
(1)
Angioedema
(9)
Antigen-Specific Immunity
(3)
Autoantibodies
(30)
Autoimmunity
(21)
Autoinflammatory
(3)
Biologicals
(6)
Blotting-LIA
(1)
Clinical-Immunology
(34)
Consensus Guidelines
(3)
CSF
(2)
Cytokines
(15)
Dermatomyositis
(2)
Diabetes
(4)
Drug Allergy
(7)
Drug Antibodies
(3)
ELISA
(9)
Erythropoietin
(1)
FceRI
(3)
Functional-Assays
(5)
GAD
(2)
Gardasil
(3)
Gastrointestinal
(2)
Genetic testing
(24)
HAE - Hereditary Angioedema
(4)
Haematological-Oncology
(4)
Hyper-IgE-Syndrome
(5)
Iatrogenic
(9)
Immunochemistry-Biochemical-Analytes
(2)
Immunodeficiency-Infection
(22)
Immunofluorescence
(7)
Immunomodulation
(6)
Inflammatory Disorders
(3)
Interferon
(4)
Laboratory-Immunology
(84)
LAMP
(6)
Neuroimmunology
(2)
Novel Immunoassays
(1)
Paraproteins
(2)
Pemphigus - Pemphigoid
(7)
Periodic Fever
(3)
Quality Assurance-Quality Control
(3)
Quorn
(1)
Scleroderma
(2)
Standardisation
(7)
TLR
(6)
Toll Like Receptor
(6)
Urticaria
(5)
Vaccination
(3)
WHIM
(3)
Wednesday, December 12, 2012
FceRI Antibodies - From William Smith
My understanding is that there are still no commercial tests, the area has been difficult for technical reasons and also for reasons of test peformance- poor specificity in immunoassays, poor correlation between immuno and functional assays. Functional assays (BAT and histamine release) remain gold standard but reproducibility is poor and difficult to commercialise.
Regards, William
Regards, William